Entera Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-8.89	-13.07	-12.19	-11.22	-10.8	-10.3	-11.2	-1.2
Depreciation & Amortization	0.06	0.06	0.05	0.06	0.24	0.05	0.04	0.04
Share-Based Compensation	1.69	2.25	1.86	0.9	1.48	1.23	4.89	1.49
Other Operating Activities	-0.17	-1.74	1.21	-0.31	0.16	-0.78	1.74	-3.47
Operating Cash Flow	-7.31	-12.5	-9.06	-10.56	-8.92	-9.8	-4.53	-3.14
Capital Expenditures	-0.02	-0.05	-0.02	-0.05	-0.04	-0.07	-0.05	-0.04
Acquisitions	0	-0.06	0	0	0	0	0	0
Change in Investments	0	0	0	0	4	-4	0	0
Other Investing Activities	-	-	-	-	-0.01	-	1.05	-1.08
Investing Cash Flow	-0.02	-0.1	-0.02	-0.05	3.95	-4.07	1	-1.12
Share Issuance / Repurchase	6.62	0.01	25.38	4.05	12.77	9.62	0	0
Debt Issued / Paid	0	0	0	0	-0.11	0	-0.98	7.22
Other Financing Activities	-0.58	-	-	-	-	-	12.09	-
Financing Cash Flow	6.04	0.01	25.38	4.05	12.65	9.62	11.11	7.22
Net Cash Flow	-1.29	-12.59	16.3	-6.56	7.68	-4.24	7.58	2.96
Free Cash Flow	-7.33	-12.55	-9.08	-10.61	-8.96	-9.86	-4.58	-3.18
Free Cash Flow Margin	-	-9362.69%	-1590.19%	-2906.85%	-3796.19%	-1972.80%	-	-
Free Cash Flow Per Share	-0.25	-0.44	-0.35	-0.58	-0.74	-1.24	-1.02	-0.71

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).